Stephen Gordon - Mar 4, 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon
Stock symbol
TMDX
Transactions as of
Mar 4, 2024
Transactions value $
-$665,100
Form type
4
Date filed
3/5/2024, 06:20 PM
Previous filing
Feb 27, 2024
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $577K +15K +59.52% $38.46 40.2K Mar 4, 2024 Direct F1
transaction TMDX Common Stock Sale -$1.24M -15K -37.31% $82.80 25.2K Mar 4, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -15K -22.23% $0.00 52.5K Mar 4, 2024 Common Stock 15K $38.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.